Model
Edge
Halozyme Therapeutics, Inc.
0001662521
Filing type
4
Filing date
May 6, 2026
Updated
May 7, 2026 ยท 5:01 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership